Interferon-β increases the stimulatory capacity of monocyte-derived dendritic cells to induce IL-13, IL-5 and IL-10 in autologous T-cells

Journal of Neuroimmunology

Volumn 123, Issue 1-2, 2002, Pages 160-169

  Wiesemann, Elke ^a   Sönmez, Daniela ^a   Heidenreich, Fedor ^a   Windhagen, Anja ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokines; Dendritic cells; Interferon

Indexed keywords

BETA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5;

ARTICLE; AUTOIMMUNITY; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD1; DENDRITIC CELLS; HUMANS; INTEGRIN ALPHAXBETA2; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-5; MONOCYTES; RECEPTORS, INTERFERON; T-LYMPHOCYTES;

EID: 0036184261     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00482-9     Document Type: Article

References (40)

1. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
2. Dendritic cells and the control of immunity
3. Immunobiology of dendritic cells
4. IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: Selective inhibition of CD40-dependent interleukin-12 secretion
5. Interferon affects cell growth progression by modulating DNA polymerases activity
6. Dendritic cells as natural adjuvants
7. Active immunization of humans with dendritic cells
8. How can dendritic cells cause autoimmune disease?
9. Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: An alternative to standard buffy coats
10. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
11. Interferon-beta induces the development of type 2 dendritic cells
12. + subset of human blood dendritic cells is a direct precursor of Langerhans cells
13. + T cells: Modulation by interleukin-4 and interleukin-12
14. Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses
15. + dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation
16. Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns
17. Dendritic cells signal T cells in the absence of exogenous antigen
18. Interferon beta induces T-helper 2 immune deviation in MS
19. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells
20. Vaccination with autologous dendritic cells: From experimental autoimmune encephalomyelitis to multiple sclerosis
21. Introduction: TH2-inducing DC2 for immunotherapy
22. + T cells to secrete IL-4
23. Role of dendritic cells in the induction and maintenance of autoimmune diseases
24. Type I IFNs enhance the terminal differentiation of dendritic cells
25. Type I interferons keep activated T cells alive
26. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system
27. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development
28. IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells
29. Interferon-alpha and-beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors
30. 3H Thymidine incorporation assay
31. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis
32. Reciprocal control of T helper cell and dendritic cell differentiation
33. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
34. Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis
35. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis
36. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
37. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis
38. Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis?
39. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells
40. Dendritic cells and the pathogenesis of rheumatoid arthritis